Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|May 27, 2025
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI studyNicola Squillace, Elena Delfina Ricci, Giancarlo Orofino, et al.
AIDS (London, England)|February 1, 2024
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they?Claudia Bartalucci, Federico Baldi, Elena Ricci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 26, 2013
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)Barbara Menzaghi, Elena Ricci, Laura Carenzi, et al.
Viruses|May 28, 2022
Reversibility of Central Nervous System Adverse Events in Course of ArtLucia Taramasso, Giancarlo Orofino, Elena Ricci, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 10, 2026
Distance from low-density lipoprotein cholesterol targets across cardiovascular risk strata in people living with HIV: a multicentre cohort studyGiuseppe Vittorio De Socio, Anna Gidari, Elena Delfina Ricci, et al.
Plos One|July 19, 2012
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experienceAmedeo Capetti, Simona Landonio, Paola Meraviglia, et al.
Infection and Drug Resistance|May 8, 2018
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA ProjectPaola Bagella, Giuseppe Vl De Socio, Elena Ricci, et al.
International Journal of Antimicrobial Agents|December 10, 2013
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E StudyAmedeo Capetti, Paola Meraviglia, Simona Landonio, et al.
Viruses|March 30, 2023
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life StudyAndrea De Vito, Elena Ricci, Barbara Menzaghi, et al.
Pageof 7